OEM : Pharmaceutical
It takes unwavering commitment and confidence to bring solutions from the petri dish to patients. And it requires a continued investment in innovation to address the known and unknown challenges of tomorrow. Since our launch in 2013, we have invested ~$50 billion in research to discover, develop and deliver new medicines. We target diseases with significant unmet need where we can improve the standard of care with innovative new therapies. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.